Stock CTNM CONTINEUM THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Contineum Therapeutics, Inc.

Equities

CTNM

US21217B1008

Real-time Estimate Cboe BZX
Other stock markets
 02:32:20 2024-05-24 pm EDT 		5-day change 1st Jan Change
15.4 USD -4.41% Intraday chart for Contineum Therapeutics, Inc. +1.87% 0.00%
Apr. 30 Morgan Stanley Starts Contineum Therapeutics With Overweight Rating MT
Apr. 30 Stifel Starts Contineum Therapeutics With Buy Rating, $29 Price Target MT

Turnover - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. CTNM Stock
  4. Revisions Contineum Therapeutics, Inc.